Drug & medication recalls

VistaPharm, Inc. recalls Nystatin Oral Suspension, USP, 100,000 units/mL, packaged in a) 2 fl.oz. (60mL) bottles (NDC 66689-008-02), and 500,000…

Recall date
May 17, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0869-2017
FDA classification
Class III
Brand / firm
VistaPharm, Inc.
Sold / distributed
Nationwide in the US and Puerto Rico

Why it was recalled

Failed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Nystatin Oral Suspension, USP, 100,000 units/mL, packaged in a) 2 fl.oz. (60mL) bottles (NDC 66689-008-02), and 500,000 units/5mL individual unit dose cup (NDC 66689-037-01) packaged in b) 50 count unit dose cups/case (NDC 66689-037-50) and c) 100 count unit dose cups/case (NDC 66689-037-99) Rx only, Manufactured by: VistaPharm, Largo, FL 33771.

Get recall alerts

Free email alert whenever VistaPharm, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: VistaPharm, Inc.